May 05, 2022 / 09:00AM GMT
Operator
Good morning, ladies and gentlemen, and welcome to the Arecor Therapeutics plc year-end results investor presentation. (Operator Instructions) Before we begin, I would like to submit the following poll. And if you could give that your kind attention, I'm sure the company would be most grateful.
And I'd now like to hand you over to CEO, Sarah Howell. Good morning to you.
Sarah Jennifer Howell - Arecor Therapeutics plc - CEO & Director
Good morning. Thank you, Jake. So good morning, everybody. Thank you for taking the time to join us today. It's a pleasure to be here. So my name is Dr. Sarah Howell, I'm the CEO of Arecor, and I'm joined today by Susan Lowther, our CFO. And today we really will give you an introduction to Arecor, our technology and the proprietary products that we're developing and also kind of some of the highlights from our year ending 31st of December 2021.
So to draw your attention to our customary legal notice. So by wave introduction at Arecor, we -- our purpose here is to transform patient care by enhancing existing
Arecor Therapeutics PLC to Present the Year End Results Transcript
May 05, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers